Acceptance of the HPV vaccine and suggested strategies to promote vaccine uptake: a qualitative study with a multi-ethnic sample of Latina mothers (Preprint)

2020 ◽  
Author(s):  
Ana Cristina Lindsay ◽  
Madelyne J. Valdez ◽  
Denisse Delgado Vazquez ◽  
Emily Restrepo ◽  
Yessica M. Guzman ◽  
...  

BACKGROUND Parents play a critical decision-making role in vaccinating their age-eligible adolescent children against HPV. Despite evidence indicating that Latino adolescents have higher HPV vaccination rates than non-Hispanic whites, uptake of the HPV vaccine remains lower than the 80% goal set by the Healthy People 2020. Moreover, studies suggest that Latino adolescent males have lower rates of HPV vaccination than Latina adolescent females. OBJECTIVE Given the importance of the HPV vaccination as a cancer prevention strategy and the unique decision-making role parents play in vaccinating their children, this study was designed to explore Latina mothers’: (1) acceptance of the HPV vaccine, and (2) suggested strategies to promote vaccine uptake among Latino parents and their adolescent children. METHODS A descriptive qualitative research employing individual semi-structured interviews. Data were analyzed using a hybrid method of thematic analysis that incorporated deductive and inductive approaches. RESULTS Twenty-two, majority foreign-born (91%; n = 20) Latina mothers of adolescent girls (~ 60%; n = 23) and boys (~ 40%; n = 15) aged between 11 and 19 years (mean age of adolescents: 15.3 years) participated in the study. Results revealed mothers’ high acceptance of the HPV vaccine for their daughters and their positive beliefs about the direct benefits of the vaccine to protect their daughters’ health by preventing STI and future cervical cancer risk. Such positive beliefs influenced mothers’ high uptake and initiation of the vaccine for their daughters. In contrast, study findings revealed mothers’ low acceptance and uptake of the vaccine for their sons. Our findings showed that the majority of mothers did not perceiving HPV infection as a major risk to their sons’ health, and therefore, did not perceive direct health benefits of the HPV vaccine for their sons as they did for their daughters (i.e., prevention of cervical cancer). CONCLUSIONS Findings identified the need for increased efforts to raise awareness and knowledge among Latino parents of the direct benefits of the vaccine for their sons and the cancer prevention benefits of the vaccine for HPV-associated cancers that affect not only females but also males. Finally, findings underscore the need for improved healthcare providers' communication and recommendation of the HPV vaccine for Latino adolescent males. Future research should intervene upon findings identified in this study in order to address barriers that remain and affect Latino parents’ acceptance and uptake of the HPV vaccine for their children, and in particular, for their sons. CLINICALTRIAL n/a

Afrika Focus ◽  
2016 ◽  
Vol 29 (2) ◽  
Author(s):  
Heleen Vermandere

HPV vaccination prevents cervical cancer, the fourth most common cancer among women worldwide. Measured HPV vaccine acceptability is often high but does it also lead to high uptake? Methodology: A cohort was set up assessing HPV vaccine acceptability and other health behav- iour constructs before, and vaccine uptake after an HPV vaccination programme in Eldoret, Kenya. Focus groups shed light on the motivation for vaccine uptake or refusal. Results: Acceptability was high but was no strong predictor of uptake, and neither were the constructs of the Health Belief Model. Lack of information and fear of side effects were major barriers. Feeling uncomfortable to discuss cervical cancer hampered open communication. Discussion: Distrust towards new vaccines and the health system blocked translation from willingness-to-vaccinate to actual uptake, as did organizational factors such as poor promotion. Conclusion: Future research should include broader concepts such as vaccine hesitancy and factors beyond personal control in order to predict vaccine uptake. Key words: HPV vaccination, acceptability, uptake, longitudinal study, Kenya 


2019 ◽  
Vol 4 (4) ◽  
pp. 165-169
Author(s):  
Mastura Mohd Sopian ◽  
Sharifah Azdiana Tuan Din ◽  
Hasmah Hussin

Cervical cancer, along with breast, colorectal, and lung cancer, has become increasingly problematic in Malaysia. The prevalence of cervical cancer in Malaysia is projected to rise in younger women, and Malaysia views this prediction with concern and awareness of the need to take action to prevent the illness among those who are currently healthy. Providing free HPV vaccination is a way to lower the risk of developing cervical cancer among women in Malaysia. However, while Malaysia has been able to provide this vaccination at minimal or no cost, changes in socio-economic circumstances have stretched the demand. This review aims to highlight the probability of HPV vaccination acceptance and the reasons for it. An extensive literature review of acceptance, knowledge, attitude, practice, and decision making about HPV vaccination was performed to describe issues related to vaccination. The evidence presented herein can help identify ways to improve the HPV vaccination program in Malaysia.


2018 ◽  
Vol 4 (Supplement 1) ◽  
pp. 18s-18s
Author(s):  
Verónica Cordoba ◽  
Olga Lucía Tovar-Aguirre ◽  
Sandra Franco ◽  
María del Pilar Escobar ◽  
Nelson Enrique Arias ◽  
...  

Abstract 43 Purpose Colombia implemented a school-based human papillomavirus (HPV) vaccination program that consisted of a three-dose series in girls age 9 years in 2012. In 2014, the program included girls up to the last grade of high school, and the second and third doses were scheduled at 6 and 60 months. After a mass psychogenic response after vaccination that occurred from May to October 2014 in Carmen de Bolivar, vaccination rates dropped from 80% in 2012 and 2013 to 18% in 2014. The aim of the current study was to identify barriers and facilitators of HPV vaccine uptake in Colombia. Methods To develop quantitative instruments for a population-based survey, we conducted 19 qualitative interviews and 18 focus groups between September 2016 and February 2017. Participants were girls who were eligible to receive vaccination between 2012 and 2014 and their parents or legal representatives. Results Forty-nine girls who were selected from six schools of low (n = 2), medium (n = 2), and high (n = 2) socioeconomic level and 58 of their parents participated in the study. Eighty-one percent (40 of 49) of girls were age 12 to 15 years at the time of interview. No girls from schools of a low socioeconomic level and only two of 20 of their parents knew the etiology of cervical cancer. Pap smear cytology and condom use were the methods of cervical cancer prevention that were most often mentioned by parents. Only vaccinated girls from schools of a high socioeconomic level considered the HPV vaccine to be a good prevention alternative. Facilitators in adults were the desire to prevent disease in general and HPV. For both girls and their parents, listening to positive information about the vaccine facilitated vaccine uptake. Negative media information about the effects of the vaccine from the 2014 psychogenic event was the main barrier for vaccine uptake or series completion. Fifty-seven percent of girls and 30% of parents mentioned that, at the time of vaccination, information about the HPV vaccine was received mainly through government massive media campaigns, whereas approxiamtely one half of both parents and girls did not receive information from schools or health care services. Conclusion Our results suggest that improving HPV vaccination rates in Colombia will require a comprehensive education program, including mass media information about the HPV vaccine. AUTHORS' DISCLOSURES OF POTENTIAL CONFLICTS OF INTEREST No COIs from the authors.


2021 ◽  
Vol 3 ◽  
Author(s):  
W. Gill Woodall ◽  
Gregory Zimet ◽  
Alberta Kong ◽  
David Buller ◽  
Jeannyfer Reither ◽  
...  

U.S. HPV vaccine uptake remains below the Healthy People 2030 goal of 80% series completion. Parental concerns and misinformation about the efficacy and safety of the Human Papillomavirus (HPV) vaccine remain, and may be addressed by digital interventions tailored to their concerns. Reported here are results from a small scale randomized trial testing a mobile web app for parents and their adolescent daughters (ages 11–14 years) encouraging HPV vaccination in New Mexico, an ethnically-diverse U.S. state.Methods: A clinic-cluster randomized trial where pediatric clinics (n = 9) were recruited and randomized, and parent-adolescent pairs (n = 82) within clinics received either the Vacteens.org/Vacunadolescente.org mobile web app or Usual and Customary (UC) HPV Vaccination information. Parents completed online surveys at baseline and 3-months. Daughters' HPV vaccine data were collected from the New Mexico State Immunization Information System 1 year post baseline.Results: Three month survey results found Vacteens.org/Vacunadolescente.org parents to have higher positive HPV vaccine beliefs, informed decision making, intent to vaccinate and vaccine confidence outcomes than UC parents. HPV vaccine data found higher first dose HPV vaccination (Pearson χ2 = 6.13, p = 0.013, Vacteens.org/Vacunadolescente.org group 59.4%, UC group 40.6%), and higher HPV vaccination series completion (Pearson χ2 = 6.49, p = 0.011, Vacteens.org/Vacunadolescente.org group 68.4%, UC group 31.6%).Conclusions: The small trial results showed the Vacteens.org/Vacunadolescente.org web app prompted positive vaccine-related attitudes and beliefs, and more HPV vaccination initiation and series completion. Mobile web apps can make decision-making tools for HPV vaccination widely available on digital platforms, reducing vaccine hesitancy, and confusion and increase HPV vaccine uptake.


Author(s):  
Susie Susilawati ◽  
Dwiana Ocviyanti

Objective: To evaluate the role of hospitals in DKI Jakarta on primary and secondary cervical cancer prevention. Method: This was a survey conducted to 25 hospitals, chosen with simple random sampling from 109 hospitals in DKI Jakarta. Questionnaire used for interview contained statements regarding knowledge, attitude and behavior of 117 health care professionals along with identification of facility preparedness for cervical cancer prevention within those 25 hospitals. Result: The assessment of knowledge shows that all health care professionals (100%) knew that HPV vaccination is used as a primary prevention for cervical cancer. About 98.3% respondent knew HPV vaccine injected intramuscularly. As much as 91.5% of the respondent knew HPV vaccine is given three times either at month 0, 1, 6 or at month 0, 2, 6. About 71.8% respondent knew deltoid as site for vaccine injection. Most of health care professionals (99.1%) knew VIA (visual inspection with acetic acid) can be used for early detection of cervical cancer. About 76.9% respondent knew how to interpret positive VIA results and 60.7% respondent knew how to do VIA test. As much as 93.2% health care professional knew the purpose of Pap test and about 82.1% knew how to do it. From attitude aspect, most of health care professionals (96.6%) agreed in giving HPV vaccination. About 94% of them agreed to do VIA test and about 98.3% agreed in conducting Pap test. From behavioral aspect, most of the respondent (76.9%) offered HPV vaccination to their clients/patients and 62.4% respondent did HPV vaccination. VIA test was offered and conducted by 52.1% and 30.8% of them, respectively. About 86.3% respondent offered Pap test and 71.8% did the Pap test. As many as 75% of female health care professionals who meet the qualification already had a Pap test for themselves, but only 32.5% ever been vaccinated for HPV. From facility aspect, twenty hospitals (80%) in DKI Jakarta offered HPV vaccination with Pap test can be done in all of them. VIA test and colposcopy were only available in eleven (44%) and ten (40%) hospitals respectively. Conclusion: Most hospitals in DKI Jakarta have health care professionals with good knowledge and attitude in cervical cancer prevention. However, not many have shown expected behavior in the primary prevention. Most hospitals in DKI Jakarta provide facilities for HPV vaccination and Pap test, but only few have VIA facilities and colposcopy. Keywords: cervical cancer prevention, health care professional, hospital


2019 ◽  
Author(s):  
Serena Xiong ◽  
Maiyia Y. Kasouaher ◽  
Bai Vue ◽  
Kathleen A. Culhane-Pera ◽  
Shannon L. Pergament ◽  
...  

Abstract Background: Human papillomavirus (HPV) vaccination rates in Asian-American/Pacific- Islander (AAPI) populations are substantially lower than majority Americans. No studies have assessed HPV vaccine rates in the Hmong population, an AAPI group with increased risks of cervical and nasopharyngeal cancer. In 2015, the HPV vaccinations rates for Hmong girls and boys ages 9-17 at a Minnesota community health center (CHC) were 32% and 20%, lower than national 2017 HPV rates of 47% and 53%. This qualitative community-based participatory action research study identified multilevel barriers, facilitators, and decision-making processes about HPV vaccinations among Hmong adolescents and parents. Methods: Bilingual community researchers recruited Hmong adolescents and their parents from a community health center, conducted eight focus groups with 12 adolescents and 13 parents. Participants also completed demographic and HPV knowledge surveys. The research team analyzed transcripts using participatory thematic analysis and identified themes using a multilevel socioecological model combined with an assets lens. Results: Both survey and focus group results showed that Hmong adolescents and parents had low levels of HPV and HPV vaccine awareness. At the individual-level, both adolescents and parents reported concerns about side-effects and cost as reasons for not getting any type of vaccination, however they also expressed a strong desire to learn about HPV and the HPV vaccine. Community-level barriers identified included community narratives around traumatic experiences with vaccines, and facilitators included family and community connections and communications. At the institutional-level, barriers included structural constraints in health care settings, while facilitators included ease of obtaining vaccines at school-based clinics and provider authoritative decision-making. Finally, there was a range of decision-making processes between parents and adolescents and between parents and providers. Conclusion: A linguistically and culturally-specific HPV educational program for Hmong adolescents and parents could address barriers and build on facilitators and assets to promote HPV vaccine uptake. These findings have informed the development of an eHealth application to increase HPV vaccinations in Hmong adolescents. Future research will test the feasibility, acceptability, and efficacy of culturally-tailored, multilevel HPV vaccination interventions that may provide evidence about the efficacy of culturally-appropriate education in comprehensive vaccine strategies.


Author(s):  
Nicholas Yared ◽  
Molly Malone ◽  
Estee Welo ◽  
Inari Mohammed ◽  
Emily Groene ◽  
...  

Abstract Background Human papillomavirus (HPV) vaccination rates among adolescents are increasing in Minnesota (MN) but remain below the Healthy People 2020 goal of 80% completion of the series. The goal of this study was to identify messaging and interventions impacting HPV vaccine uptake in MN through interviews with clinicians and key stakeholders. Methods We conducted semi-structured key participant interviews with providers and stakeholders involved in HPV vaccination efforts in MN between 2018 and 2019. Provider interview questions focused on messaging around the HPV vaccine and clinic-based strategies to impact HPV vaccine uptake. Stakeholder interview questions focused on barriers and facilitators at the organizational or state level, as well as initiatives and collaborations to increase HPV vaccination. Responses to interviews were recorded and transcribed. Thematic content analysis was used to identify themes from interviews. Results 14 clinicians and 13 stakeholders were interviewed. Identified themes were grouped into 2 major categories that dealt with messaging around the HPV vaccine, direct patient–clinician interactions and external messaging, and a third thematic category involving healthcare system-related factors and interventions. The messaging strategy identified as most useful was promoting the HPV vaccine for cancer prevention. The need for stakeholders to prioritize HPV vaccination uptake was identified as a key factor to increasing HPV vaccination rates. Multiple providers and stakeholders identified misinformation spread through social media as a barrier to HPV vaccine uptake. Conclusion Emphasizing the HPV vaccine’s cancer prevention benefits and prioritizing it among healthcare stakeholders were the most consistently cited strategies for promoting HPV vaccine uptake. Methods to combat the negative influence of misinformation about HPV vaccines in social media are an urgent priority.


Author(s):  
Henon Gebre ◽  
Senya Ghamli ◽  
Frederica Jackson ◽  
Bhakti Chavan ◽  
Caroline Kingori

Background: Immigrants in the US are at higher risk of Human Papilloma Virus (HPV) infection and cervical cancer compared to the general US population. Low awareness surrounding cervical cancer inhibits associated preventive practices.  Purpose: This cross-sectional study examined the association between knowledge, attitude, and utilization of health services for cervical cancer screening and HPV vaccine among immigrant and refugee women in Ohio.  Method: Preliminary analyses were conducted on a total of 70 participants recruited from immigrant and refugee organizations and community centers, using a validated paper survey.  Results: There was a statistically significant association between cervical cancer screening and general knowledge on cervical cancer (p = 0.038). The study also revealed association between screening age (p < 0.001) and insurance status (p = 0.033).  Majority of the participants perceived HPV vaccine to be ineffective at preventing cervical cancer, and 40.8% participants had never heard of the vaccine and consequently had not been vaccinated. 94% participants did not receive the HPV vaccine, however, 65.3% participants indicated willingness to be vaccinated against HPV for free or at reduced cost.  Conclusion: Culturally appropriate interventions are warranted to develop effective strategies that will influence HPV screening behavior and vaccine uptake in this target population. 


2021 ◽  
Vol 9 ◽  
Author(s):  
Madan Khatiwada ◽  
Cissy Kartasasmita ◽  
Henny Suzana Mediani ◽  
Christine Delprat ◽  
Guido Van Hal ◽  
...  

Introduction: Cervical cancer, a major consequence of persistent HPV infection, is the third most common cancer in women worldwide and has claimed around 311,000 women lives in 2018. The majority of these deaths took place in low- and middle-income countries (LMICs). In LMICs, where cervical cancer screening coverage is low, the HPV vaccine is a promising tool for preventing HPV infections and, thus, averting cervical cancer cases. In Indonesia, cervical cancer is the second most common cancer and HPV vaccination demonstration programs are underway in several provinces, but the HPV vaccine has not yet been introduced nationally. Since students are an important source of information for the community, and medical and nursing students are the future healthcare professionals, this study explored the knowledge, attitude, and acceptability of the HPV vaccine among University students in Indonesia.Methodology: A self-administered online questionnaire was used to assess the knowledge, attitude, and willingness of University students toward HPV vaccination.Result: A total of 433 students from Medical, Nursing, Social Sciences, and other faculties participated in the survey. It was identified that over 90% of the students were aware of cervical cancer and HPV, but only 68% knew about the HPV vaccine before participating in the study. Despite an average knowledge on the HPV vaccine, the students showed a strong willingness to receive the vaccine (95.8% acceptance rate). They believed that the HPV vaccine is safe and effective and that it will protect against HPV infection. The high cost and the lack of adequate information flow on HPV-related topics have been identified as potential barriers to the adoption of the HPV vaccine in Indonesia.Conclusion: Despite a high willingness for HPV vaccine uptake among students, there is a need to provide education on HPV vaccine-related topics to Indonesian students through awareness and training programs and improving the academic curriculum on vaccination for the long-term sustainability of the HPV vaccination program.


Afrika Focus ◽  
2016 ◽  
Vol 29 (2) ◽  
pp. 117-121
Author(s):  
Heleen Vermandere

Introduction: HPV vaccination prevents cervical cancer, the fourth most common cancer among women worldwide. Measured HPV vaccine acceptability is often high but does it also lead to high uptake? Methodology: A cohort was set up assessing HPV vaccine acceptability and other health behaviour constructs before, and vaccine uptake after an HPV vaccination programme in Eldoret, Kenya. Focus groups shed light on the motivation for vaccine uptake or refusal. Results: Acceptability was high but was no strong predictor of uptake, and neither were the constructs of the Health Belief Model. Lack of information and fear of side effects were major barriers. Feeling uncomfortable to discuss cervical cancer hampered open communication. Discussion: Distrust towards new vaccines and the health system blocked translation from willingness- to-vaccinate to actual uptake, as did organizational factors such as poor promotion. Conclusion: Future research should include broader concepts such as vaccine hesitancy and factors beyond personal control in order to predict vaccine uptake.


Sign in / Sign up

Export Citation Format

Share Document